Home for the Holiday: Last-gasp Drug Saves Seattle Baby’s Life
Source: The Seattle Times
A Seattle baby is home in time for Christmas after local doctors bet on a last-chance, once-discarded treatment that uses liquid, not air, to inflate the collapsed lungs of fragile newborns. Tatiana Saiaana, now nearly 4 months old, smiled and stared with big brown eyes at a sparkling tree in her family’s Seward Park-area home this week, safe in the lap of her mother, Elise Pele, 28. “She’s doing great,” Pele said, cuddling the sturdy girl in the leopard-print sleeper. Just weeks ago, Tatiana was one of the most critically ill babies doctors at Seattle Children’s had ever seen. Before her birth via emergency cesarean section on Aug. 29, Tatiana had inhaled meconium, a mixture of fetal stool and amniotic fluid, causing severe respiratory distress.
About Seattle Children’s
Seattle Children’s mission is to provide hope, care and cures to help every child live the healthiest and most fulfilling life possible. Together, Seattle Children’s Hospital, Research Institute and Foundation deliver superior patient care, identify new discoveries and treatments through pediatric research, and raise funds to create better futures for patients.
Ranked as one of the top children’s hospitals in the country by U.S. News & World Report, Seattle Children’s serves as the pediatric and adolescent academic medical center for Washington, Alaska, Montana and Idaho – the largest region of any children’s hospital in the country. As one of the nation's top five pediatric research centers, Seattle Children’s Research Institute is internationally recognized for its work in neurosciences, immunology, cancer, infectious disease, injury prevention and much more. Seattle Children’s Hospital and Research Foundation works with the Seattle Children’s Guild Association, the largest all-volunteer fundraising network for any hospital in the country, to gather community support and raise funds for uncompensated care and research.
For more information, visit seattlechildrens.org or follow us on Twitter, Facebook, Instagram or on our On the Pulse blog.